Substituted benzimidazoles, processes for their preparation, their use as medicaments, and medicaments comprising them

US6958357B2 · kind B2 · utility

Assignee

• Aventis Pharma Deutschland GmbH · DE

Inventors

• Armin Hofmeister · Frankfurt, DE
• Uwe Heinelt · Wiesbaden, DE
• Hans-Jochen Lang · Hofheim, DE
• Markus Bleich · Brechen, DE
• Klaus Wirth · Frankfurt am Main, DE
• Michael Gekle · Coburg, DE

Key dates

• Filing date: May 20, 2003
• Grant date: Oct 25, 2005
• Expiry date: May 20, 2023

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to the use of compounds of formula I for the production of a medicament for the treatment of illnesses which can be influenced by inhibition of the Na+/H+ exchanger, and to a medicament comprising them. in which R1 to R9 have the meanings shown in the claims.